North Star Asset Management Inc. bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,981 shares of the company’s stock, valued at approximately $1,411,000.
Other hedge funds have also recently modified their holdings of the company. ADAR1 Capital Management LLC purchased a new position in Merck KGaA during the 2nd quarter worth $403,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of Merck KGaA in the second quarter valued at about $942,087,000. Whalen Wealth Management Inc. purchased a new stake in shares of Merck KGaA in the second quarter valued at about $1,600,000. Cibc World Market Inc. acquired a new position in shares of Merck KGaA during the second quarter worth about $186,005,000. Finally, Madison Wealth Partners Inc purchased a new position in Merck KGaA during the second quarter worth about $1,031,000. 0.10% of the stock is owned by institutional investors and hedge funds.
Merck KGaA Price Performance
Shares of OTCMKTS:MKGAF opened at $158.15 on Friday. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The company has a 50-day moving average price of $163.21 and a 200 day moving average price of $148.95. The company has a market cap of $20.44 billion, a P/E ratio of 24.14 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
